Loading clinical trials...
Loading clinical trials...
This is a Phase 2a, 2-part study (designated Parts A and B) that will evaluate APP13007 dose strength and dosing frequency in a randomized double-masked fashion for comparison to the respective matchi...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Formosa Pharmaceuticals, Inc.
Cornea and Cataract Consultants of Arizona
Phoenix, Arizona
United Medical Research Institute
Inglewood, California
Martel Eye Medical Group
Rancho Cordova, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions